Evidence map›Paper›PMID 31109348›Full record

ArticleParasites & vectors2019

Barriers to the National Onchocerciasis Control Programme at operational level in Cameroon: a qualitative assessment of stakeholders' views.

Fanny Nadia Dissak-Delon, Guy-Roger Kamga, Perrine Claire Humblet, Annie Robert, Jacob Souopgui, Joseph Kamgno, Stephen Mbigha Ghogomu, Isabelle Godin

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Entomological Assessment ofPathogens (Basel, Switzerland) · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Fanny Nadia Dissak-DelonMinistry of Public Health, N°8, Rue 3038 quartier du Lac, Yaounde, Cameroon. fannynadia@gmail.com.ORCID http://orcid.org/0000-0001-8386-6501
Guy-Roger KamgaMinistry of Public Health, N°8, Rue 3038 quartier du Lac, Yaounde, Cameroon.
Perrine Claire HumbletEcole de Santé Publique - Campus Erasme, Université Libre de Bruxelles, Route de Lennik 808 CP591, 1070, Brussels, Belgium.
Annie RobertInstitut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Clos Chapelle-aux-champs 30 bte B1.30.13, 1200, Brussels, Belgium.
Jacob SouopguiInstitute of Molecular Biology and Medicine, Université Libre de Bruxelles, Rue des professeurs Jeener et Brachet 12, Gosselies, 6041, Charleroi, Belgium.
Joseph KamgnoCentre for Research on Filariasis and other Tropical Diseases, P.O. Box 5797, Yaounde, Cameroon.
Stephen Mbigha GhogomuMolecular and Cell Biology Laboratory, Department of Biochemistry and Molecular Biology, University of Buea, P.O. Box 63, Buea, Cameroon.
Isabelle GodinEcole de Santé Publique - Campus Erasme, Université Libre de Bruxelles, Route de Lennik 808 CP591, 1070, Brussels, Belgium.
Université Libre de Bruxelles · BEUniversity of Buea · CMUCLouvain · BEUniversité de Yaoundé I · CM

Funding

ARES CCD (Belgium) PRD2013CameroonSouopgui
6 · The paper itself

Abstract

backgroundThe global burden of onchocerciasis is the heaviest in sub-Saharan Africa. Studies have shown the importance of the role of Community-Directed Distributors (CDDs) and nurses in onchocerciasis control, but little is known about their experience in implementing onchocerciasis control programmes. Our aim was to document the barriers that CDDs and local health administrators face in implementing onchocerciasis control activities.

methodsWe conducted a qualitative survey consisting of 16 in-depth interviews and 8 focus group discussions (FGDs) across three health districts of Cameroon. We interviewed a total of 9 local health officials at the district and Health Area levels, and 7 CDDs. Eight FGDs were conducted with CDDs and Health Committee members.

resultsThe major barriers to the implementation of Community Directed Treatment with Ivermectin that we identified were linked and interrelated. Examples of these barriers included: contextual factors (geographical and cultural background), top-to-bottom planning, insufficient human and material resources, and lack of transparency in the management of the programme's funds.

conclusionsThe CDTI at operational level still faces many obstacles which negatively affect therapeutic coverages. This can lead to the non-adhesion of the communities to the programme, consequently jeopardizing the sustainability of the onchocerciasis elimination programme. We recommend that the national programme planners put in place a transparent management and planning system for onchocerciasis elimination activities, with better communication with local programme stakeholders.

Indexed as

Program EvaluationStakeholder ParticipationAfrica South of the SaharaAnimalsAntiparasitic AgentsCameroonCommunity Health ServicesCommunity Health WorkersCost of IllnessEvaluation Studies as TopicFemaleFilaricidesFocus GroupsHealth Plan ImplementationHumansInfection ControlAntiparasitic AgentsFilaricidesIvermectinCommunity interventionOnchocerciasisQualitative surveyStakeholders experience

Identifiers

PMID31109348
PMCPMC6528230
OpenAlexW2946971915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.